Robot-assisted surgery for perihilar cholangiocarcinoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the use of robotically assisted surgery for patients diagnosed with perihilar cholangiocarcinoma, a challenging type of bile duct cancer. It aims to evaluate the effectiveness and safety of minimally invasive surgical techniques in achieving complete tumor resection, which is crucial for improving long-term survival rates. The study will include patients who meet specific eligibility criteria, including age and histological confirmation of the disease, and will assess outcomes related to surgical success and recovery. The approach is designed to minimize complications and enhance recovery compared to traditional open surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age≥18 years
* Histologically proven pCCA or highly presumed bile duct malignancy with difficulties to obtain histological evidence with negative Immunoglobulin G4 (IgG4 sample)
* Preoperative staging work up performed by abdomen enhanced CT scan.
* The subject understands the nature of this trial and is willing to comply.
* Ability to provide written informed consent.
* Patients treated with curative intent in accordance to international guidelines

Exclusion Criteria:

* Distant metastases: peritoneal carcinomatosis, liver metastases, distant lymph node metastases, involvement of other organs.
* Previous radiotherapy
* Vascular encasement
* Patients with high operative risk as defined by the American Society of Anesthesiologists (ASA) score\>4.
* Synchronous malignancy in other organs.
* Palliative surgery

Where it's running

• Azienda Ospedaliera di Padova
  Padova, Italy Recruiting

Study contacts

• Study coordinator: Umberto Prof. Cillo, MD
• Email: cillo@unipd.it
• Phone: +390498211846

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PET imaging that targets CLDN18.2 to find stomach, pancreatic, bile-duct, and esophageal cancers

  This project will try a CLDN18.2-targeted PET scan in adults with suspected or confirmed gastric, pancreatic, bile-duct, or esophageal cancer (and some healthy volunteers) to see if it can show CLDN18.2-positive tumors.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07301814

• In-depth characterisation of biliary strictures and hepato‑pancreato‑biliary focal lesions to support new diagnostic technologies

  This project will collect detailed imaging and tissue data from adults with suspected bile duct, liver, pancreatic, or gallbladder lesions to help develop and test better diagnostic tools.

  Recruiting University of Nottingham · Nottingham · NCT07206355

• Preoperative Lymph Node Assessment in Cholangiocarcinoma using Endoscopic Ultrasound

  This study tests how well preoperative endoscopic ultrasound (EUS) finds lymph node metastases in adults with presumed resectable or certain unresectable cholangiocarcinomas to see if surgery should proceed.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland and 5 other locations · NCT07161869

• Liver transplantation for patients with advanced bile duct cancer

  This study is testing if liver transplantation can help patients with advanced bile duct cancer who have controlled their disease with treatment.

  Recruiting Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Milan, Michigan · NCT06986486

• Neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab vs upfront surgery for cancers of the bile ducts

  This trial tests whether giving chemotherapy with pembrolizumab before surgery helps people with resectable or borderline resectable extrahepatic cholangiocarcinoma see if they have better outcomes than going straight to surgery.

  Recruiting Phase 2/3 Amsterdam UMC, location VUmc · Amsterdam · NCT06923475

• Observing the effects of intra-arterial therapies for liver cancer

  This study is trying to find the best ways to help people with liver cancer get better results from a treatment called intra-arterial therapy.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06774690

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.